According to AlphaMoat, in October 2026 Orakl Oncology (orakl-oncology.com) received 1,363 monthly visits (+19.5% MoM) — ranked #15,928 of 17,609 AI websites with traffic data, and #2,749 of 3,112 in Industry Services; its largest market is France (98.9% of visits).
Orakl Oncology is an AI platform for oncology drug discovery that says it is building a native [AIxBio] engine: teaching AI to decode biology from its own datasets, predicting how disease evolves and how patients will respond to new drugs, to lower drug-development risk and open a new therapeutic era.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 1.3K | — |
| 2026-07 | 3.3K | +159.9% |
| 2026-08 | 2.1K | -35.1% |
| 2026-09 | 1.1K | -46.2% |
| 2026-10 | 1.4K | +19.5% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, Orakl Oncology (orakl-oncology.com) received 1,363 visits (about 1.4K) in October 2026 (+19.5% month over month), ranking #15,928 of 17,609 AI websites with traffic data, and #2749 in Industry Services.
In October 2026, Orakl Oncology’s largest markets by share of visits are France 98.9%, Japan 1.1%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.